Home page  |  About this library  |  Help  |  Clear       English  |  French  |  Spanish  
Expand Document
Expand Chapter
Full TOC
Preferences
to previous section to next section

close this bookWHO Recommended Surveillance Standards (WHO; 1999; 157 pages)
View the documentAcknowledgements
View the documentAcronyms
View the documentIntroduction
View the documentNational Coordination of Communicable Disease Surveillance
View the documentExplanatory notes
View the documentSurveillance activities: criteria and WHO Department
View the documentCommunicable disease contacts in Regional Offices
close this folderDiseases
View the documentB20-B21-B22-B23-B24 AIDS
View the documentA22 Anthrax
View the documentA23 Brucellosis
View the documentA00 Cholera
View the documentA81.0 Creutzfeldt-Jakob disease
View the documentA90, A91 Dengue fever (A90) including Dengue haemorrhagic fever (DHF) & Dengue shock syndrome (DSS, A91)
View the documentA36 Diphtheria
View the documentB72 Dracunculiasis (Guinea worm disease)
View the documentA98.3, A98.4 Ebola-Marburg viral diseases
View the documentA83.0 Japanese encephalitis
View the documentB74 Lymphatic filariasis
View the documentB96.3 Haemophilus influenzae type b
View the documentB15-B17 Acute viral hepatitis
View the documentB20-B24 HIV infection
View the documentJ10, J11 Influenza
View the documentA96.2 Lassa fever
View the documentA48.1 Legionellosis
View the documentB55.1, B55.2 Cutaneous leishmaniasis
View the documentLeishmania / HIV co-infections
View the documentB55.0 Visceral leishmaniasis
View the documentA30 Leprosy
View the documentA27 Leptospirosis
View the documentB50-54 Malaria
View the documentB05 Measles
View the documentA39 Meningococcal disease
View the documentA87 Viral meningitis
View the documentB73 Onchocerciasis
View the documentA37.0 Pertussis
View the documentA20 Plague
View the documentA36 Poliomyelitis
View the documentA82 Rabies
View the documentA02.0 Salmonellosis
View the documentB65 Schistosomiasis
View the documentA50-52 Syphilis
View the documentA33 Tetanus, neonatal
View the documentB56-0, B56-1 African trypanosomiasis
View the documentB57 American trypanosomiasis
View the documentA15-A19 Tuberculosis
View the documentA75.3 Scrub typhus
View the documentA95.9 Yellow fever
open this folder and view contentsSyndromes
View the documentAnnex 1 Software free and in the public domain
View the documentAnnex 2 Proposed surveillance definitions
View the documentAnnex 3 Role and use of Geographic Information Systems (GIS) and mapping for epidemiological surveillance
 

A48.1 Legionellosis

(Legionnaires' disease, Legionnaires' pneumonia)

RATIONALE FOR SURVEILLANCE

Legionnaires' disease is a disease with epidemic potential and high case-fatality. Surveillance is important in order to detect epidemics and to institute appropriate investigations and control measures. In addition, the surveillance of sporadic disease may provide clues as regards source of disease and prevention.

RECOMMENDED CASE DEFINITION

Clinical description

An illness characterized by an acute lower respiratory infection with focal signs of pneumonia on clinical examination and/or radiological evidence of pneumonia.

Laboratory criteria for diagnosis

Presumptive: one or more of the following:

 

• Detection of specific legionella antigen in respiratory secretions or urine

• Direct fluorescent antibody (DFA) staining of the organism in respiratory secretions or lung tissue, using evaluated monoclonal reagents

• A fourfold or greater rise in specific serum antibody titre to legionella species other than Legionella pneumophila serogroup 1, using a locally validated serological test

Confirmative: one or more of the following:

 

• Isolation of Legionella from respiratory secretions, lung tissue, pleural fluid, or blood

• A fourfold or greater rise in specific serum antibody titre to L. pneumophila serogroup 1 by indirect immunofluorescence antibody test or microagglutination

 

Note: Most European countries and others such as the United States now include the detection of L. pneumophila serogroup 1 antigen in urine as a confirmatory test.

Case classification

Suspected: Not applicable.

Probable: A case compatible with the clinical description, with presumptive laboratory results.

Confirmed: A case compatible with the clinical description, with confirmative laboratory results.

RECOMMENDED TYPES OF SURVEILLANCE

Immediate reporting of case-based data from periphery to intermediate and central levels.

The identification of cases should prompt immediate investigation for risk factors and other cases. For a rapid response, active case finding is preferred.

International: Since travel and stays in hotels are important risk factors, effective international surveillance is essential to identify and control the point source of infections.

Legionella infection is usually diagnosed after the patient's return to the country of residence and is therefore likely to be considered as a sporadic, single case.

A surveillance scheme such as the European Working Group for Legionella Infections* (see Special Aspects) allows for the detection of clusters of cases (≥2 cases) with the same source of transmission, as case notifications from different European countries are collected in the same database.

 

* European Working Group on Legionella Infections, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 SEQ Tel: (44) 181 200 6868 E-mail: Fax: (44) 181 200 7868

RECOMMENDED MINIMUM DATA ELEMENTS

Case-based data for investigation and reporting

 

• Unique identifier, name, age, sex, geographical information, date of onset, outcome

• Underlying risk factors (e.g., immunocompromised patient, AIDS)

• Exposure risk factors (hospitalizations, hotels, or other accommodation and travel history during the 2 weeks before the onset)

• Laboratory data (specimen type, date collected, Legionella spp. isolated)

RECOMMENDED DATA ANALYSES, PRESENTATION, REPORTS

 

• Review data regularly to look for clusters of cases in time, place or person (this should be undertaken at all levels)

• Incidence of infection by month, geographical area, age group, risk factors, exposure factors

PRINCIPAL USES OF DATA FOR DECISION-MAKING

 

• Detect clusters/outbreaks
• Identify high risk areas and exposures
• Monitor impact of environmental control measures

SPECIAL ASPECTS

There are 2 currently recognized distinct clinicoepidemiological manifestations of legionellosis:

 

• "Legionnaires' disease" (pneumonic form) and
• "Pontiac fever" (non-pneumonic Legionnaires' disease)

Both are characterized initially by anorexia, vomiting, myalgia and headache, followed within a day by rising fevers and chills.

In the pneumonic form, non-productive cough, abdominal pain/diarrhoea, confusion/delirium are common. It is not possible, clinically, to distinguish Legionella pneumonia from other pneumonias; suspicion should be raised in any pneumonia connected with epidemiological information (e.g., recent travelling, hospitalization, gatherings, immunosuppression). In addition, age (>50), sex (M), smoking, alcohol consumption have been shown to be risk factors.

Pontiac fever is not associated with pneumonia. It is thought to represent a reaction to inhaled antigen, rather than to bacteria.

The reservoir of Legionella spp. is probably primarily aqueous (e.g., hot water systems, air-conditioning, cooling towers and evaporative condensers). Environmental surveillance for Legionella in water sources can be undertaken usually as part of registration and licensing procedures. In any event, environmental surveillance should be undertaken for known sources of outbreaks, to ensure that the organism is eradicated.

CONTACT

Regional Offices:

See Regional Communicable Disease contacts on section "Communicable disease contacts in Regional Offices".

Headquarters: 20 Avenue Appia, CH-1211 Geneva 27, Switzerland

Communicable Diseases Surveillance and Response (CSR)

 

E-mail: tikhomirove@who.ch / outbreak@who.ch
Tel: (41 22) 791 2656/2850/2111
Fax: (41 22) 791 4878/0746 attn CSR
to previous section to next section

Please provide your feedback   English  |  French  |  Spanish